This test is a MOLECULAR TEST to detecting genetic material of the Covid-19 virus. The test is considered a RAPID test and results will be given to the patient within the same day of testing. The target population for this test is patients with Covid-19 Symptoms within the first 7 days of symptom onset. This test is not FDA approved. The test is available under an emergency access mechanism called an Emergency Use Authorization (EAU).
ID NOW uses isothermal technology, proprietary enzymes and constant temperature control to achieve the fastest available RNA amplification. This proven molecular system greatly reduces the time for results, allowing healthcare providers to make patient care decisions sooner.
To conduct a test, a swab of the nose is taken. Then the swab is placed into an acidic liquid solution heated to 132.8⁰ F that cracks open the envelope of the SARS-CoV-2 virus, exposing its viral RNA.
Then the small device, about the size of a toaster and weighing only 6.6 pounds, amplifies the RNA hundreds of millions of times to make the virus detectable — returning test results in 13 minutes or less
As of February 24, 2021 NY State requires screening testing for In-Person and catered events over 50 people (ex: Weddings, Business Events, Proms) or provide proof of having COMPLETED the Covid-19 Vaccine series 14 days prior to event. Venues may still choose to require testing. This FDA authorized NUCLEIC ACID AMPLIFICATION test (Abbott ID Now) may be used if performed within 72 hours of the event start time. Attendees must present proof of a NEGATIVE test result prior to arrival of the event.
As of 2/14/21 all people traveling into Canada require a Nucleic Acid Amplification test, such as the Abbott ID Now with confirmation of a negative result. Please click link for more information on traveling to Canada.